Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity.
[This corrects the article DOI: 10.1371/journal.pone.0166415.].
Main Author: | PLOS ONE Staff |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5313219?pdf=render |
Similar Items
-
An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity.
by: Jing Lu, et al.
Published: (2016-01-01) -
Making the final cut: pathogenic amyloid-β peptide generation by γ-secretase
by: Harald Steiner, et al.
Published: (2018-10-01) -
Computer-Aided Drug Design of β-Secretase, γ-Secretase and Anti-Tau Inhibitors for the Discovery of Novel Alzheimer’s Therapeutics
by: Varnavas D. Mouchlis, et al.
Published: (2020-01-01) -
α-Synuclein increases β-amyloid secretion by promoting β-/γ-secretase processing of APP.
by: Hazel L Roberts, et al.
Published: (2017-01-01) -
ABCG1 and ABCG4 Suppress γ-Secretase Activity and Amyloid β Production.
by: Osamu Sano, et al.
Published: (2016-01-01)